66 filings
8-K
IDYA
Ideaya Biosciences Inc
12 Mar 24
IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
6:04am
8-K
IDYA
Ideaya Biosciences Inc
20 Feb 24
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023
6:07am
8-K
IDYA
Ideaya Biosciences Inc
23 Jan 24
Other Events
6:03am
8-K
IDYA
Ideaya Biosciences Inc
19 Jan 24
Entry into a Material Definitive Agreement
5:18pm
8-K
IDYA
Ideaya Biosciences Inc
16 Jan 24
Other Events
6:07am
8-K
z79tzaj4ku8
12 Jan 24
Other Events
6:04am
8-K
knzuz3qnsh0wkxj
4 Dec 23
IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy® and IDE397 Combination in MTAP-Deletion Bladder Cancer
6:04am
8-K
3x9vwk41up 4w3lc0
17 Nov 23
Entry into a Material Definitive Agreement
6:02am
8-K
hzj7matsbqiud9t9
7 Nov 23
IDEAYA Biosciences, Inc. Reports Third Quarter 2023
6:01am
8-K
j0azaftpb
27 Oct 23
Other Events
4:23pm
8-K
njozll6
24 Oct 23
Results of Operations and Financial Condition
4:21pm
8-K
64yaxx9
23 Oct 23
Other Events
8:09am
8-K
a64hl
26 Sep 23
Departure of Directors or Certain Officers
6:05am
8-K
ye2ss3
10 Aug 23
IDEAYA Biosciences, Inc. Reports Second Quarter 2023
6:01am
8-K
3e8 jwtq4
3 Jul 23
Departure of Directors or Certain Officers
4:01pm
8-K
3wivr00rtn
30 Jun 23
Entry into a Material Definitive Agreement
4:01pm
8-K
0liinj 2v4zrb
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
xrams97lcf3xla3d
6 Jun 23
Entry into a Material Definitive Agreement
6:02am
8-K
w9bosi 2mlk
16 May 23
IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
6:02am
8-K
dp5ok
9 May 23
IDEAYA Biosciences, Inc. Reports First Quarter 2023 Financial Results
6:01am